Virios Therapeutics (VIRI) Institutional Ownership $0.57 -0.03 (-4.96%) (As of 11/27/2023 ET) Add Compare Share Share Today's Range$0.57▼$0.6250-Day Range$0.46▼$1.0752-Week Range$0.22▼$2.42Volume184,252 shsAverage Volume928,573 shsMarket Capitalization$11.07 millionP/E RatioN/ADividend YieldN/APrice TargetN/A OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Virios Therapeutics (NASDAQ:VIRI)CurrentInstitutional OwnershipPercentage10.96%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$377,728.26Number ofInstitutional Sellers(last 12 months)0 Get VIRI Insider Trade Alerts Want to know when executives and insiders are buying or selling Virios Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VIRI Institutional Buying and Selling by Quarter Virios Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2023Citadel Advisors LLC33,298$46K0.0%N/A0.182% 8/14/2023State Street Corp52,828$73K0.0%+397.1%0.289% 8/11/2023Geode Capital Management LLC147,269$0.20M0.0%+144.3%0.805% 8/8/2023Belvedere Trading LLC18,142$25K0.0%N/A0.099% 7/28/2023McCollum Christoferson Group LLC30,700$42K0.0%N/A0.168% 5/16/2023Susquehanna International Group LLP161,811$59K0.0%+343.3%1.943% Get the Latest News and Ratings for VIRI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023Envestnet Asset Management Inc.120,663$44K0.0%+10.5%1.449% 2/13/2023Renaissance Technologies LLC235,400$56K0.0%+33.3%2.826% 2/7/2023Envestnet Asset Management Inc.109,196$26K0.0%+576.3%1.311% 11/14/2022Renaissance Technologies LLC176,600$67K0.0%N/A2.120% 11/7/2022Warberg Asset Management LLC200,000$74K0.0%N/A2.401% 10/13/2022PVG Asset Management Corp80,590$31K0.1%N/A0.967% 8/15/2022State Street Corp10,628$45K0.0%N/A0.128% 7/12/2022Koshinski Asset Management Inc.40,924$0.17M0.0%N/A0.491% 7/6/2022Wiley BROS. Aintree Capital LLC11,000$47K0.0%N/A0.132% 5/16/2022UBS Group AG14,137$63K0.0%+528.3%0.170% 5/13/2022Vanguard Group Inc.241,666$1.08M0.0%+63.4%2.901% 5/12/2022Cetera Advisors LLC43,944$0.20M0.0%+22.0%0.528% 11/16/2021Captrust Financial Advisors40,145$0.21M0.0%N/A0.482% 11/16/2021Cetera Advisors LLC48,432$0.26M0.0%+100.0%0.581% 11/16/2021Masters Capital Management LLC650,000$3.44M0.1%+8.3%7.803% 11/9/2021BlackRock Inc.15,856$84K0.0%+64.3%0.190% 9/17/2021Virtu Financial LLC13,110$82K0.0%N/A0.157% 8/13/2021Geode Capital Management LLC18,499$0.12M0.0%N/A0.222% 8/13/2021Vanguard Group Inc.141,011$0.89M0.0%N/A1.693% 5/18/2021Millennium Management LLC22,858$0.13M0.0%+10.4%0.274% 5/17/2021Masters Capital Management LLC600,000$3.44M0.1%+33.9%7.203% 5/14/2021PVG Asset Management Corp55,160$0.32M1.0%N/A0.662% 5/4/2021Envestnet Asset Management Inc.27,844$0.16M0.0%N/A0.334% 2/24/2021Virtu Financial LLC35,219$0.26M0.0%N/A0.450% 2/17/2021Jane Street Group LLC95,230$0.72M0.0%N/A1.216% (Data available from 1/1/2016 forward) VIRI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VIRI shares? During the previous two years, 15 institutional investors and hedge funds held shares of Virios Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($1.08M), Geode Capital Management LLC ($0.20M), Cetera Advisors LLC ($0.20M), Koshinski Asset Management Inc. ($0.17M), Warberg Asset Management LLC ($74K), State Street Corp ($73K), and UBS Group AG ($63K).Learn more on VIRI's institutional investors. What percentage of Virios Therapeutics stock is owned by institutional investors? 10.96% of Virios Therapeutics stock is owned by institutional investors. Learn more on VIRI's institutional investor holdings. Which institutional investors have been buying Virios Therapeutics stock? Of the 15 institutional investors that purchased Virios Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Renaissance Technologies LLC ($0.24M), Warberg Asset Management LLC ($0.20M), Susquehanna International Group LLP ($0.13M), Envestnet Asset Management Inc. ($0.10M), Vanguard Group Inc. ($93.80K), Geode Capital Management LLC ($86.98K), and PVG Asset Management Corp ($80.59K). How much institutional buying is happening at Virios Therapeutics? Institutional investors have bought a total of 1,133,314 shares in the last 24 months. This purchase volume represents approximately $1.33M in transactions. Related Companies: Landos Biopharma Major Shareholders Context Therapeutics Major Shareholders Onconova Therapeutics Major Shareholders NanoViricides Major Shareholders Vallon Pharmaceuticals Major Shareholders Mustang Bio Major Shareholders Aytu BioPharma Major Shareholders Aprea Therapeutics Major Shareholders GeoVax Labs Major Shareholders Vincerx Pharma Major Shareholders This page (NASDAQ:VIRI) was last updated on 11/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virios Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.